The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jan. 26, 2021
Filed:
Jan. 17, 2020
Applicant:
Principia Biopharma, Inc., South San Francisco, CA (US);
Inventors:
Jiang Zhu, San Ramon, CA (US);
Mohammad Masjedizadeh, San Jose, CA (US);
Assignee:
PRINCIPIA BIOPHARMA, INC., South San Francisco, CA (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 471/04 (2006.01); A61P 35/00 (2006.01); C07B 35/02 (2006.01); C07B 35/06 (2006.01); C07B 39/00 (2006.01); C07B 43/04 (2006.01); C07B 43/06 (2006.01); C07B 45/04 (2006.01);
U.S. Cl.
CPC ...
C07D 471/04 (2013.01); A61P 35/00 (2018.01); C07B 35/02 (2013.01); C07B 35/06 (2013.01); C07B 39/00 (2013.01); C07B 43/04 (2013.01); C07B 43/06 (2013.01); C07B 45/04 (2013.01); C07B 2200/13 (2013.01);
Abstract
Disclosed herein are processes for preparing 8-(3-(4-acryloylpiperazin-1-yl)propyl)-6-(2,6-dichloro-3,5-dimethoxyphenyl)-2-(methylamino)pyrido[2,3-d]pyrimidin-7(8H)-one and FGFR inhibitor, as well as polymorphs and/or salt forms thereof.